Detalhe da pesquisa
1.
Global consensus process to establish a core dataset for hidradenitis suppurativa registries.
Br J Dermatol
; 190(4): 510-518, 2024 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37976235
2.
The Global Hidradenitis Suppurativa Atlas (GHiSA) Methodology: Combining Global Proportions in a Pooled Analysis.
Dermatology
; 2024 Feb 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38354718
3.
Hidradenitis suppurativa tarda: defining an understudied elderly population.
Br J Dermatol
; 190(1): 105-113, 2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-37665963
4.
Guselkumab for hidradenitis suppurativa: a phase II, open-label, mode-of-action study.
Br J Dermatol
; 188(5): 601-609, 2023 04 20.
Artigo
Inglês
| MEDLINE | ID: mdl-36811949
5.
Adalimumab in conjunction with surgery compared with adalimumab monotherapy for hidradenitis suppurativa: A Randomized Controlled Trial in a real-world setting.
J Am Acad Dermatol
; 89(4): 677-684, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-37116615
6.
Clindamycin-Benzoyl Peroxide Gel Compared with Clindamycin Lotion for Hidradenitis Suppurativa: A Randomized Controlled Assessor-Blinded Intra-Patient Pilot Study.
Dermatology
; 239(4): 670-674, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-37080176
7.
Validity and Reliability of Two Digital Wound Measurement Tools after Surgery in Patients with Hidradenitis Suppurativa.
Dermatology
; 239(1): 99-108, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-35998557
8.
Viewpoint on the evaluation of severity and treatment effects in mild hidradenitis suppurativa: the cumulative IHS4 (IHS4-C).
Dermatology
; 2023 Dec 20.
Artigo
Inglês
| MEDLINE | ID: mdl-38118429
9.
External Validation of the IHS4-55 in a European Antibiotic-Treated Hidradenitis Suppurativa Cohort.
Dermatology
; 239(3): 362-367, 2023.
Artigo
Inglês
| MEDLINE | ID: mdl-36630943
10.
Development and validation of IHS4-55, an IHS4 dichotomous outcome to assess treatment effect for hidradenitis suppurativa.
J Eur Acad Dermatol Venereol
; 37(2): 395-401, 2023 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-36184889
11.
Factors associated with treatment satisfaction in patients with hidradenitis suppurativa: results from the Global VOICE project.
Br J Dermatol
; 187(6): 927-935, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36056741
12.
The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study.
J Am Acad Dermatol
; 85(2): 369-378, 2021 08.
Artigo
Inglês
| MEDLINE | ID: mdl-33484766
13.
What causes hidradenitis suppurativa ?-15 years after.
Exp Dermatol
; 29(12): 1154-1170, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33058306
14.
Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial.
J Am Acad Dermatol
; 80(1): 80-88, 2019 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-30482392
15.
High prevalence of hidradenitis suppurativa in patients with perianal fistula.
Int J Colorectal Dis
; 34(7): 1337-1339, 2019 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-31093736
16.
Factors associated with disease-specific life impact in patients with hidradenitis suppurativa: results from the Global VOICE project.
Br J Dermatol
; 188(6): 808-810, 2023 05 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36891871
17.
Damage in hidradenitis suppurativa: receiving the deserved attention.
Br J Dermatol
; 187(3): 282-283, 2022 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35508388
18.
Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study.
J Am Acad Dermatol
; 76(1): 49-53, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27793450
19.
Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch Cohort.
Dermatology
; 238(3): 600-602, 2022.
Artigo
Inglês
| MEDLINE | ID: mdl-34649257
20.
Long-term treatment with apremilast in hidradenitis suppurativa: A 2-year follow-up of initial responders.
J Am Acad Dermatol
; 85(1): 258-260, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32891782